Rense.com




Could This Be The Cure For Cancer?
ThisIsBristol.com
7-16-2


Researchers have discovered a protein in the kidneys that has the power to starve tumours by blocking their blood supply, thereby stopping them spreading.
 
The discovery could lead to the development of drugs to treat a wide range of cancers, as well as arthritis, diabetes and other conditions.
 
Dr Dave Bates, who led the research alongside Dr Steve Harper at Bristol University, said:
 
"We are very excited about this. Theoretically it could apply to any cancer."
 
His team discovered the protein during tests on non-cancerous kidneys.
 
The protein is normally only seen in diseased tissue. There, it promotes the growth of blood vessels which feed a tumour and encourage the cancer to grow.
 
But the scientists found that when it occurs in normal kidneys it does not generate tumours.
 
This is because the protein, called vascular endothelial growth factor, switches in type. Dr Bates said: "The next aim of the research group is to determine if, and how, this new molecule might be useful as a treatment for cancer, vascular disease, arthritis and other diseases.
 
"We are now looking at other types of cancer to see whether they also use the same process. Particularly we are looking at prostate cancer in collaboration with Southmead hospital.We are also examining bladder cancer, lung and breast cancers."
 
The protein is also involved in the growth of plaque in the arteries, rheumatoid arthritis and a diabetic condition called retinopathy which can cause blindness.
 
Dr Bates said the team is trying to discover what causes the protein to change forms. "If you can find a drug that can switch it back, you'll stop blood vessel growth, " he said.
 
The Welcome Trust and British Heart Foundation are funding research and the Association for International Cancer Research has also now pledged its support.
 
It is likely to be between five and 10 years before human trials take place.
 
The Western Daily Press reported last month how lung cancer patients in the West have some of the lowest survival rates in Europe.
 
The disease claims the lives of 56 men per 100,000, compared with a national figure of 31 and a European figure of 13.
 
One in three people is diagnosed with cancer at some time in their life, and one in four die as a result.
 
Breast, lung, prostate and bowel cancer are the most common forms of the disease.
 
http://www.thisisbristol.com/displayNode.jsp?nod





MainPage
http://www.rense.com


This Site Served by TheHostPros